glp-1 inflammation reduction Frontiers glp-1 inflammation Potential Use of

The concentration of GLP-2 will increase rapidly after eating, and then it will be hydrolyzed by DPP-4 at the first two amino acid residues of GLP-2 (1-33) to non-bioactive GLP-2 (3-33)

While the data is promising, its still early

GLP-1 receptor agonists are approved by the FDA for managing type 2 diabetes, as well as for obesity or overweight individuals with obesity-related conditions such as high cholesterol or nonalcoholic fatty liver disease

Arts J, Holvoet L, Caenepeel P, Bisschops R, Sifrim D, Verbeke K, et al

This prolongs feelings of fullness, reducing the urge to snack between meals and lowering calorie intake